治疗阻塞性睡眠呼吸暂停的患者的表型化,具有持续的客观性警觉障碍或主观性嗜睡
Pierre Tankéré1, Jacques Taillard2, Emeric Stauffer3
1Center for Sleep Medicine, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France; Grenoble Alpes University, HP2 Laboratory (Hypoxia Pathophysiology), INSERM U1300 Grenoble, France; Lyon Neuroscience Research Center, PAM Team, INSERM U1028 / CNRS UMR 5292 / Lyon 1 University, Lyon, France.
Sleep medicine
|August 29, 2024
概括
剩余的嗜睡和警觉性受损影响超过三分之一的阻塞性睡眠呼吸暂停 (OSA) 患者,尽管治疗. 吸烟和高BMI是警觉性受损的关键风险因素,即使没有主观的嗜睡.
科学领域:
- 睡眠医学 睡眠医学
- 肺部病理学 肺部病理学
- 神经学 神经学
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 与重大风险有关,包括事故和心血管问题.
- 一个显著的百分比的OSA患者经历持续的嗜睡,尽管治疗.
- 在接受治疗的OSA患者中,导致残留的嗜睡和警觉障碍的因素尚不清楚.
研究的目的:
- 调查残留主观嗜睡的决定因素.
- 为了确定与治疗OSA患者的客观性警觉受损相关的因素.
- 为了比较有或没有残留嗜睡或警觉性受损的患者之间的临床和多睡眠学参数.
主要方法:
- 用维护清醒测试 (MWT) 和爱普沃思睡眠度量 (ESS) 评估了一组141名为OSA治疗的患者.
- 收集了临床数据,多睡眠学参数和事故史.
- 使用多变量逻辑回归来确定与MWT和ESS结果相关的变量.
主要成果:
- 超过三分之一的患者表现出客观性警觉受损和/或主观性嗜睡.
- 事故史,吸烟和ESS得分较高与客观警觉性受损有关.
- 客观警觉性受损但没有主观嗜睡的患者往往有更高的BMI,并且是吸烟者.
结论:
- 在接受治疗的OSA患者中,很大一部分患者经历了持续的嗜睡或警觉性受损.
- 综合评估,包括事故史和并发症,对于管理OSA患者至关重要.
- 高BMI的吸烟者需要特别注意,因为他们可能会在没有主观投诉的情况下降低警觉.
相关概念视频
Sleep Apnea
131
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
131
Sleep-Wake Cycles
1.2K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.2K
Narcolepsy
95
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
95
Sleepwalking and Sleep Talking
131
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
131
Insufficient Sleep and Sleep Deprivation
137
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
137
Sedatives and Hypnotics Drugs: Miscellaneous Agents
159
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
159


